BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 25114520)

  • 1. Pulmonary function impairment in patients with combined pulmonary fibrosis and emphysema with and without airflow obstruction.
    Kitaguchi Y; Fujimoto K; Hanaoka M; Honda T; Hotta J; Hirayama J
    Int J Chron Obstruct Pulmon Dis; 2014; 9():805-11. PubMed ID: 25114520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between quantitative CT metrics and pulmonary function in combined pulmonary fibrosis and emphysema.
    Ando K; Sekiya M; Tobino K; Takahashi K
    Lung; 2013 Dec; 191(6):585-91. PubMed ID: 24085320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respiratory mechanics measured by forced oscillation technique in combined pulmonary fibrosis and emphysema.
    Mori K; Shirai T; Mikamo M; Shishido Y; Akita T; Morita S; Asada K; Fujii M; Hozumi H; Suda T; Chida K
    Respir Physiol Neurobiol; 2013 Jan; 185(2):235-40. PubMed ID: 23117106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of pulmonary function in patients with COPD, asthma-COPD overlap syndrome, and asthma with airflow limitation.
    Kitaguchi Y; Yasuo M; Hanaoka M
    Int J Chron Obstruct Pulmon Dis; 2016; 11():991-7. PubMed ID: 27274220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chronic obstructive pulmonary disorder (COPD) patients with the syndrome of combined pulmonary fibrosis and emphysema, compared to patients with emphysema alone].
    Weiner P; Novitzky T; Weiner D; Beckerman M
    Harefuah; 2013 May; 152(5):294-8, 308, 307. PubMed ID: 23885455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics of combined pulmonary fibrosis and emphysema.
    Kitaguchi Y; Fujimoto K; Hanaoka M; Kawakami S; Honda T; Kubo K
    Respirology; 2010 Feb; 15(2):265-71. PubMed ID: 20051048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The objective evaluation of obstructive pulmonary diseases with spirometry.
    Ozkaya S; Dirican A; Tuna T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2009-15. PubMed ID: 27616884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of efficacy of long-acting bronchodilators in emphysema dominant and emphysema nondominant chronic obstructive pulmonary disease.
    Fujimoto K; Kitaguchi Y; Kanda S; Urushihata K; Hanaoka M; Kubo K
    Int J Chron Obstruct Pulmon Dis; 2011; 6():219-27. PubMed ID: 21660299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute exacerbations of COPD versus IPF in patients with combined pulmonary fibrosis and emphysema.
    Zantah M; Dotan Y; Dass C; Zhao H; Marchetti N; Criner GJ
    Respir Res; 2020 Jun; 21(1):164. PubMed ID: 32605574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of the desaturation-distance ratio from the six-minute walk test for patients with COPD.
    Fujimoto Y; Oki Y; Kaneko M; Sakai H; Misu S; Yamaguchi T; Mitani Y; Yasuda H; Ishikawa A
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2669-2675. PubMed ID: 28919734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative computed tomography measurements of emphysema for diagnosing asthma-chronic obstructive pulmonary disease overlap syndrome.
    Xie M; Wang W; Dou S; Cui L; Xiao W
    Int J Chron Obstruct Pulmon Dis; 2016; 11():953-61. PubMed ID: 27226711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Respiratory Impedance is Associated with Ventilation and Diffusing Capacity in Patients with Idiopathic Pulmonary Fibrosis Combined with Emphysema.
    Yamamoto Y; Hirata H; Shiroyama T; Kuge T; Matsumoto K; Yoneda M; Yamamoto M; Naito Y; Suga Y; Fukushima K; Miyake K; Koyama S; Iwahori K; Nagatomo I; Takeda Y; Kumanogoh A
    Int J Chron Obstruct Pulmon Dis; 2022; 17():1495-1506. PubMed ID: 35801120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of comorbidities on COPD assessment: a pilot study.
    Weinreich UM; Thomsen LP; Bielaska B; Jensen VH; Vuust M; Rees SE
    Int J Chron Obstruct Pulmon Dis; 2015; 10():429-38. PubMed ID: 25750525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Annual changes in pulmonary function in combined pulmonary fibrosis and emphysema: over a 5-year follow-up.
    Kitaguchi Y; Fujimoto K; Hayashi R; Hanaoka M; Honda T; Kubo K
    Respir Med; 2013 Dec; 107(12):1986-92. PubMed ID: 23850272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD.
    Pratte KA; Curtis JL; Kechris K; Couper D; Cho MH; Silverman EK; DeMeo DL; Sciurba FC; Zhang Y; Ortega VE; O'Neal WK; Gillenwater LA; Lynch DA; Hoffman EA; Newell JD; Comellas AP; Castaldi PJ; Miller BE; Pouwels SD; Hacken NHTT; Bischoff R; Klont F; Woodruff PG; Paine R; Barr RG; Hoidal J; Doerschuk CM; Charbonnier JP; Sung R; Locantore N; Yonchuk JG; Jacobson S; Tal-Singer R; Merrill D; Bowler RP
    Respir Res; 2021 Apr; 22(1):127. PubMed ID: 33906653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An autopsy study of combined pulmonary fibrosis and emphysema: correlations among clinical, radiological, and pathological features.
    Inomata M; Ikushima S; Awano N; Kondoh K; Satake K; Masuo M; Kusunoki Y; Moriya A; Kamiya H; Ando T; Yanagawa N; Kumasaka T; Ogura T; Sakai F; Azuma A; Gemma A; Takemura T
    BMC Pulm Med; 2014 Jun; 14():104. PubMed ID: 24972672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of pulmonary emphysema on COPD assessment test-oriented categorization in GOLD document.
    Suzuki T; Tada Y; Kawata N; Ikari J; Kasahara Y; Sakurai Y; Iesato K; Nishimura R; West J; Tatsumi K
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1199-205. PubMed ID: 26150711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of COPD with obstruction in active smokers with normal spirometry and reduced diffusion capacity.
    Harvey BG; Strulovici-Barel Y; Kaner RJ; Sanders A; Vincent TL; Mezey JG; Crystal RG
    Eur Respir J; 2015 Dec; 46(6):1589-1597. PubMed ID: 26541521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic change in respiratory resistance during inspiratory and expiratory phases of tidal breathing in patients with chronic obstructive pulmonary disease.
    Yamauchi Y; Kohyama T; Jo T; Nagase T
    Int J Chron Obstruct Pulmon Dis; 2012; 7():259-69. PubMed ID: 22589578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emphysematous phenotype is an independent predictor for frequent exacerbation of COPD.
    Oh YM; Sheen SS; Park JH; Jin UR; Yoo JW; Seo JB; Yoo KH; Lee JH; Kim TH; Lim SY; Yoon HI; Lee JS; Lee SD
    Int J Tuberc Lung Dis; 2014 Dec; 18(12):1407-14. PubMed ID: 25517804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.